 Evan Carey
Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Veterans | 15 | 2026 | 1603 | 2.260 |
Why?
| | Pneumonia, Ventilator-Associated | 4 | 2023 | 57 | 2.230 |
Why?
| | Pneumonia | 3 | 2023 | 631 | 1.410 |
Why?
| | Chronic Pain | 6 | 2025 | 292 | 1.070 |
Why?
| | Pain Management | 5 | 2025 | 405 | 1.000 |
Why?
| | United States Department of Veterans Affairs | 14 | 2026 | 768 | 0.990 |
Why?
| | Veterans Health | 6 | 2024 | 189 | 0.950 |
Why?
| | Cross Infection | 3 | 2025 | 262 | 0.880 |
Why?
| | Telemedicine | 5 | 2026 | 948 | 0.570 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2026 | 923 | 0.560 |
Why?
| | Kidney Diseases | 1 | 2022 | 427 | 0.550 |
Why?
| | Sepsis | 1 | 2022 | 641 | 0.460 |
Why?
| | Health Services Accessibility | 4 | 2018 | 1099 | 0.450 |
Why?
| | Depression | 3 | 2021 | 1559 | 0.450 |
Why?
| | Percutaneous Coronary Intervention | 5 | 2022 | 543 | 0.430 |
Why?
| | Oropharyngeal Neoplasms | 2 | 2025 | 55 | 0.400 |
Why?
| | Patient Care Team | 4 | 2026 | 689 | 0.400 |
Why?
| | Natural Language Processing | 2 | 2026 | 103 | 0.390 |
Why?
| | Electronic Health Records | 3 | 2026 | 1177 | 0.370 |
Why?
| | United States | 22 | 2026 | 15988 | 0.340 |
Why?
| | Papillomavirus Infections | 2 | 2025 | 345 | 0.300 |
Why?
| | Hospitals, Veterans | 4 | 2018 | 259 | 0.280 |
Why?
| | Medication Adherence | 4 | 2026 | 539 | 0.270 |
Why?
| | Humans | 42 | 2026 | 144957 | 0.260 |
Why?
| | Delivery of Health Care | 2 | 2024 | 947 | 0.230 |
Why?
| | Aged | 19 | 2026 | 25947 | 0.230 |
Why?
| | Pandemics | 3 | 2024 | 1695 | 0.220 |
Why?
| | Risk Factors | 5 | 2023 | 10792 | 0.220 |
Why?
| | Analgesics, Opioid | 3 | 2025 | 1143 | 0.220 |
Why?
| | beta-Alanine | 2 | 2015 | 23 | 0.210 |
Why?
| | Vena Cava Filters | 1 | 2025 | 64 | 0.210 |
Why?
| | Retrospective Studies | 12 | 2025 | 17101 | 0.210 |
Why?
| | Primary Health Care | 2 | 2026 | 1734 | 0.210 |
Why?
| | Papillomaviridae | 1 | 2025 | 115 | 0.210 |
Why?
| | Device Removal | 1 | 2025 | 143 | 0.210 |
Why?
| | Antithrombins | 2 | 2015 | 70 | 0.210 |
Why?
| | Documentation | 1 | 2026 | 199 | 0.200 |
Why?
| | Risk Reduction Behavior | 1 | 2026 | 226 | 0.200 |
Why?
| | Catheter-Related Infections | 1 | 2025 | 94 | 0.200 |
Why?
| | Patient Education as Topic | 4 | 2018 | 780 | 0.200 |
Why?
| | Myocardial Infarction | 4 | 2016 | 1209 | 0.200 |
Why?
| | Benzimidazoles | 2 | 2015 | 190 | 0.200 |
Why?
| | Text Messaging | 1 | 2026 | 182 | 0.190 |
Why?
| | Middle Aged | 20 | 2026 | 35928 | 0.190 |
Why?
| | DNA, Viral | 1 | 2025 | 358 | 0.190 |
Why?
| | Courage | 1 | 2022 | 3 | 0.190 |
Why?
| | Registries | 2 | 2026 | 2385 | 0.180 |
Why?
| | Heart Failure | 3 | 2025 | 2323 | 0.180 |
Why?
| | Prospective Studies | 7 | 2025 | 7997 | 0.170 |
Why?
| | Quality Assurance, Health Care | 1 | 2023 | 340 | 0.170 |
Why?
| | Population Surveillance | 1 | 2025 | 485 | 0.170 |
Why?
| | Physician-Patient Relations | 2 | 2018 | 588 | 0.170 |
Why?
| | Quality of Life | 3 | 2026 | 3192 | 0.170 |
Why?
| | Drug Monitoring | 2 | 2015 | 395 | 0.170 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 231 | 0.160 |
Why?
| | Social Support | 1 | 2025 | 652 | 0.160 |
Why?
| | Myocardial Ischemia | 1 | 2022 | 285 | 0.160 |
Why?
| | Community Health Services | 2 | 2019 | 234 | 0.160 |
Why?
| | Health Behavior | 1 | 2026 | 786 | 0.160 |
Why?
| | Bronchodilator Agents | 1 | 2021 | 183 | 0.150 |
Why?
| | Kidney Failure, Chronic | 1 | 2026 | 598 | 0.150 |
Why?
| | Acute Coronary Syndrome | 2 | 2014 | 293 | 0.150 |
Why?
| | Administration, Inhalation | 1 | 2021 | 575 | 0.150 |
Why?
| | Kidney Transplantation | 1 | 2026 | 704 | 0.150 |
Why?
| | Lung Diseases | 1 | 2026 | 787 | 0.140 |
Why?
| | Patient-Centered Care | 2 | 2015 | 544 | 0.140 |
Why?
| | Male | 19 | 2026 | 72406 | 0.140 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2025 | 1141 | 0.140 |
Why?
| | Female | 20 | 2026 | 78376 | 0.140 |
Why?
| | Vitamin D | 1 | 2022 | 400 | 0.140 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 346 | 0.140 |
Why?
| | Polysomnography | 1 | 2019 | 235 | 0.140 |
Why?
| | Comorbidity | 3 | 2018 | 1660 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1322 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2021 | 479 | 0.130 |
Why?
| | Myocardial Revascularization | 1 | 2018 | 85 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 562 | 0.130 |
Why?
| | Palliative Care | 1 | 2026 | 1008 | 0.130 |
Why?
| | Cognition | 1 | 2025 | 1269 | 0.130 |
Why?
| | Prasugrel Hydrochloride | 1 | 2016 | 22 | 0.120 |
Why?
| | Patient Discharge | 2 | 2014 | 983 | 0.120 |
Why?
| | Cohort Studies | 7 | 2025 | 5965 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 586 | 0.120 |
Why?
| | Spatial Analysis | 1 | 2016 | 23 | 0.120 |
Why?
| | Self Care | 2 | 2018 | 389 | 0.120 |
Why?
| | Coronary Artery Bypass | 1 | 2018 | 269 | 0.120 |
Why?
| | Sleep Wake Disorders | 1 | 2019 | 302 | 0.110 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5417 | 0.110 |
Why?
| | Substance-Related Disorders | 1 | 2024 | 1094 | 0.110 |
Why?
| | Cardiac Care Facilities | 1 | 2014 | 11 | 0.110 |
Why?
| | Specialties, Surgical | 1 | 2015 | 82 | 0.110 |
Why?
| | Remote Consultation | 1 | 2015 | 66 | 0.110 |
Why?
| | Early Medical Intervention | 1 | 2015 | 61 | 0.110 |
Why?
| | Aged, 80 and over | 5 | 2026 | 8279 | 0.110 |
Why?
| | Qualitative Research | 1 | 2022 | 1671 | 0.110 |
Why?
| | Incidence | 1 | 2021 | 2883 | 0.100 |
Why?
| | Medicine | 1 | 2015 | 125 | 0.100 |
Why?
| | Hospitals | 2 | 2021 | 732 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2026 | 2171 | 0.100 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 95 | 0.100 |
Why?
| | Health Status | 2 | 2016 | 836 | 0.100 |
Why?
| | Anxiety | 1 | 2021 | 1110 | 0.100 |
Why?
| | Adult | 9 | 2026 | 40506 | 0.100 |
Why?
| | Cost of Illness | 1 | 2015 | 321 | 0.090 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2016 | 497 | 0.090 |
Why?
| | Secondary Prevention | 1 | 2014 | 255 | 0.090 |
Why?
| | Atrial Fibrillation | 2 | 2015 | 550 | 0.090 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 335 | 0.090 |
Why?
| | Health Services Needs and Demand | 1 | 2013 | 280 | 0.090 |
Why?
| | Heart Diseases | 1 | 2014 | 350 | 0.080 |
Why?
| | Patient Selection | 1 | 2015 | 719 | 0.080 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 164 | 0.080 |
Why?
| | Cardiac Catheterization | 1 | 2014 | 560 | 0.080 |
Why?
| | Thrombosis | 1 | 2014 | 393 | 0.080 |
Why?
| | Hospitalization | 3 | 2022 | 2434 | 0.080 |
Why?
| | Stents | 1 | 2014 | 556 | 0.080 |
Why?
| | Longitudinal Studies | 4 | 2022 | 2947 | 0.070 |
Why?
| | Coronary Artery Disease | 1 | 2014 | 741 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2025 | 1721 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2026 | 11695 | 0.070 |
Why?
| | Cost-Benefit Analysis | 2 | 2026 | 636 | 0.070 |
Why?
| | Practice Patterns, Physicians' | 1 | 2016 | 1358 | 0.060 |
Why?
| | Asthma | 1 | 2018 | 1768 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2026 | 5872 | 0.060 |
Why?
| | Research Design | 1 | 2012 | 1137 | 0.060 |
Why?
| | Travel | 2 | 2018 | 136 | 0.060 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2026 | 133 | 0.060 |
Why?
| | Patient Reported Outcome Measures | 2 | 2022 | 489 | 0.050 |
Why?
| | Stroke | 1 | 2014 | 1258 | 0.050 |
Why?
| | Dabigatran | 2 | 2015 | 29 | 0.050 |
Why?
| | Risk Assessment | 1 | 2014 | 3676 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2026 | 405 | 0.050 |
Why?
| | Time Factors | 4 | 2016 | 7183 | 0.050 |
Why?
| | Technology | 1 | 2024 | 96 | 0.050 |
Why?
| | Ethics Committees, Research | 1 | 2023 | 41 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1980 | 0.050 |
Why?
| | Pain Measurement | 1 | 2025 | 555 | 0.050 |
Why?
| | Interdisciplinary Communication | 2 | 2015 | 197 | 0.050 |
Why?
| | Platinum | 1 | 2022 | 50 | 0.050 |
Why?
| | Prognosis | 2 | 2026 | 4293 | 0.050 |
Why?
| | Carboplatin | 1 | 2022 | 160 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2026 | 760 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2014 | 2920 | 0.040 |
Why?
| | Minority Groups | 1 | 2024 | 282 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1540 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2022 | 323 | 0.040 |
Why?
| | Hemorrhage | 2 | 2016 | 809 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 466 | 0.040 |
Why?
| | Patient Readmission | 2 | 2018 | 759 | 0.040 |
Why?
| | Medicare | 1 | 2025 | 887 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1890 | 0.040 |
Why?
| | Artificial Intelligence | 1 | 2023 | 367 | 0.040 |
Why?
| | Complementary Therapies | 1 | 2019 | 94 | 0.030 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2019 | 124 | 0.030 |
Why?
| | Occupational Therapy | 1 | 2019 | 111 | 0.030 |
Why?
| | Communication | 1 | 2024 | 967 | 0.030 |
Why?
| | Erythrocytes | 1 | 2023 | 757 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 220 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2925 | 0.030 |
Why?
| | Coronary Thrombosis | 1 | 2016 | 25 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2016 | 61 | 0.030 |
Why?
| | Off-Label Use | 1 | 2016 | 51 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 201 | 0.030 |
Why?
| | Hypesthesia | 1 | 2016 | 21 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1464 | 0.030 |
Why?
| | Physical Therapy Modalities | 1 | 2019 | 332 | 0.030 |
Why?
| | Chest Pain | 1 | 2016 | 100 | 0.030 |
Why?
| | Cost Savings | 1 | 2015 | 86 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2015 | 80 | 0.030 |
Why?
| | Mental Health | 1 | 2022 | 792 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 67 | 0.030 |
Why?
| | Prosthesis Failure | 1 | 2014 | 128 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2018 | 693 | 0.020 |
Why?
| | Pharmacists | 1 | 2015 | 240 | 0.020 |
Why?
| | Medication Reconciliation | 1 | 2012 | 31 | 0.020 |
Why?
| | Community Pharmacy Services | 1 | 2012 | 46 | 0.020 |
Why?
| | Disease Management | 1 | 2016 | 647 | 0.020 |
Why?
| | Interprofessional Relations | 1 | 2014 | 281 | 0.020 |
Why?
| | Reminder Systems | 1 | 2012 | 141 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1486 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2012 | 465 | 0.020 |
Why?
| | Young Adult | 1 | 2026 | 14126 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2836 | 0.020 |
Why?
| | Health Care Costs | 1 | 2012 | 427 | 0.020 |
Why?
| | Adolescent | 1 | 2026 | 22453 | 0.010 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2012 | 1416 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2016 | 6053 | 0.010 |
Why?
|
|
Carey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|